# LANGLARA

NDC: 87682-090
Generic name: insulin glargine-aldy
Labeler / Manufacturer: Lanexa Biologics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260701

FDA application: BLA761412

## Active ingredients

- INSULIN GLARGINE: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87682-090"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87682-090